Health / Nutrition

New Oral GLP-1 Agonist Shows Promise in Obesity Treatment

Structure Therapeutics has announced positive topline data from its ACCESS program for aleniglipron, a once-daily oral small molecule GLP-1 receptor agonist. The studies show promising results in weight loss for individuals with obesity or...